Journey Medical Corp
NASDAQ:DERM

Watchlist Manager
Journey Medical Corp Logo
Journey Medical Corp
NASDAQ:DERM
Watchlist
Price: 5.1164 USD -0.07% Market Closed
Market Cap: 102.3m USD
Have any thoughts about
Journey Medical Corp?
Write Note

Journey Medical Corp
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Journey Medical Corp
Gross Profit Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Journey Medical Corp
NASDAQ:DERM
Gross Profit
$52.5m
CAGR 3-Years
21%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Gross Profit
$60.7B
CAGR 3-Years
-1%
CAGR 5-Years
2%
CAGR 10-Years
2%
Bristol-Myers Squibb Co
NYSE:BMY
Gross Profit
$36B
CAGR 3-Years
0%
CAGR 5-Years
16%
CAGR 10-Years
12%
Pfizer Inc
NYSE:PFE
Gross Profit
$42.6B
CAGR 3-Years
-2%
CAGR 5-Years
N/A
CAGR 10-Years
1%
Merck & Co Inc
NYSE:MRK
Gross Profit
$48.4B
CAGR 3-Years
15%
CAGR 5-Years
8%
CAGR 10-Years
6%
Eli Lilly and Co
NYSE:LLY
Gross Profit
$33.1B
CAGR 3-Years
17%
CAGR 5-Years
14%
CAGR 10-Years
8%

See Also

What is Journey Medical Corp's Gross Profit?
Gross Profit
52.5m USD

Based on the financial report for Dec 31, 2023, Journey Medical Corp's Gross Profit amounts to 52.5m USD.

What is Journey Medical Corp's Gross Profit growth rate?
Gross Profit CAGR 3Y
21%

Over the last year, the Gross Profit growth was 22%. The average annual Gross Profit growth rates for Journey Medical Corp have been 21% over the past three years .

Back to Top